This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ANWAR EL-MOFTY, M.D.; ABDEL MONEM EL-MOFTY, M.D.; HASSAN ABDELAL, D.V.D.; M. F. S. EL-HAWARY, Ph.D. (London)

AMA Arch Derm. 1959;80(1):53-55.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since 1948, new drugs, psoralens (Ammoidin and Ammidin, which are 8-methoxypsoralen and 5-isoamyleneoxypsoralen, respectively), separated in crystalline form from the extracts of the fruits of an Egyptian herb, Ammi majus linn,¹ have been used with success by one of us (A. M. E-M.) in 1948^2,3 and 1949 in the treatment of leukoderma. Since then, many investigators^4-6 have tried these drugs in the treatment of leukoderma, and they have confirmed its successful results.

In our trials on these drugs for the last 10 years we were fully aware of the importance of detecting and reporting any undesirable side-effects.

The possibility of a potential danger of aggravating a diabetic process was raised when one of us (A. M. E-M., 1952⁸) reported two cases of mild diabetes where a possible aggravation of their diabetes was clinically suspected. One of these cases was a dentist, treating . . . [Full Text PDF of this Article]

Author Affiliations
Cairo, Egypt

Footnotes
Submitted for publication July 28, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?